Changes in 59Fe Uptake into Erythrocytes and Chemically Separated Heme Fractions of Spleen and Femoral Bone Marrow after Irradiation with X-rays at Different Doses in OK-432 Treated Mice.
Hisamasa Joshima, Yoshiro Aoki
Abstract
Open-access reader
Hisamasa Joshima, Yoshiro Aoki
Abstract
Open-access reader
The radiation dose range in which OK-432 would promote the recovery of radiation-impaired erythropoiesis was investigated.C57BL/6J male mice were injected with a single dose of 5 KE of OK-4321 h before or 1 h after irradiation with X-rays.Erythropoietic activity was measured by 59Fe incorporation into circulating erythrocytes and the chemically separated heme iron fraction of erythropoietic tissues.When irradiated with 94. 5 cGy to 567 cGy of X-rays the uptake of 59Fe into circulating erythrocytes was promoted within 20 days after irradiation by the treatment with OK-432.Treatment with OK-432 1 h before otherwise lethal irradiation with 662 cGy significantly enhanced the 59Fe uptake into erythrocytes.These results demonstrate that OK-432 stimulates erythropoietic recovery in sub-lethally and lethally irradiated mice.At long time intervals following irradiation with 567 cGy or 662 cGy of X-rays, the 59Fe uptake into erythrocytes in the OK-432-treated group was quite similar to the corresponding non-irradiated controls.Further studies to ascertain whether OK-432 can be used as a radioprotective agent are currently in progress.
OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
The radiation dose range in which OK-432 would promote the recovery of radiation-impaired erythropoiesis was investigated.C57BL/6J male mice were injected with a single dose of 5 KE of OK-4321 h before or 1 h after irradiation with X-rays.Erythropoietic activity was measured by 59Fe incorporation into circulating erythrocytes and the chemically separated heme iron fraction of erythropoietic tissues.When irradiated with 94. 5 cGy to 567 cGy of X-rays the uptake of 59Fe into circulating erythrocytes was promoted within 20 days after irradiation by the treatment with OK-432.Treatment with OK-432 1 h before otherwise lethal irradiation with 662 cGy significantly enhanced the 59Fe uptake into erythrocytes.These results demonstrate that OK-432 stimulates erythropoietic recovery in sub-lethally and lethally irradiated mice.At long time intervals following irradiation with 567 cGy or 662 cGy of X-rays, the 59Fe uptake into erythrocytes in the OK-432-treated group was quite similar to the corresponding non-irradiated controls.Further studies to ascertain whether OK-432 can be used as a radioprotective agent are currently in progress.
Key concepts: Irradiation, Spleen, Bone marrow, Erythropoiesis, Radiochemistry, Chemistry, Radiobiology, Nuclear medicine